News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,005 Results
Type
Article (39452)
Company Profile (249)
Press Release (654304)
Section
Business (204059)
Career Advice (2006)
Deals (35410)
Drug Delivery (93)
Drug Development (80975)
Employer Resources (169)
FDA (16146)
Job Trends (14833)
News (344947)
Policy (32484)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2541)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49335)
ALS (75)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (98)
Approvals (16129)
Artificial intelligence (211)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11637)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (232)
Cancer (1805)
Cardiovascular disease (134)
Career advice (1670)
Career pathing (28)
CAR-T (130)
Cell therapy (374)
Cervical cancer (13)
Clinical research (65411)
Collaboration (702)
Compensation (402)
Complete response letters (18)
COVID-19 (2571)
CRISPR (31)
C-suite (182)
Cystic fibrosis (97)
Data (1728)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (225)
Diagnostics (6303)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (66)
Earnings (85763)
Editorial (28)
Employer branding (21)
Employer resources (145)
Events (111237)
Executive appointments (593)
FDA (17127)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (631)
Gene editing (86)
Generative AI (18)
Gene therapy (256)
GLP-1 (662)
Government (4368)
Grass and pollen (4)
Guidances (46)
Healthcare (18792)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (91)
Indications (23)
Infectious disease (2691)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (71)
Interviews (311)
IPO (16474)
IRA (40)
Job creations (3628)
Job search strategy (1421)
Kidney cancer (9)
Labor market (27)
Layoffs (442)
Leadership (14)
Legal (7892)
Liver cancer (70)
Lung cancer (264)
Lymphoma (122)
Machine learning (2)
Management (57)
Manufacturing (248)
MASH (57)
Medical device (13288)
Medtech (13293)
Mergers & acquisitions (19346)
Metabolic disorders (585)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1754)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2225)
Now hiring (36)
Obesity (321)
Opinion (197)
Ovarian cancer (61)
Pain (70)
Pancreatic cancer (69)
Parkinson's disease (119)
Partnered (17)
Patents (181)
Patient recruitment (82)
Peanut (45)
People (56928)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20372)
Phase II (28811)
Phase III (21455)
Pipeline (813)
Podcasts (40)
Policy (102)
Postmarket research (2563)
Preclinical (8593)
Press Release (64)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (340)
Real estate (5898)
Recruiting (64)
Regulatory (22010)
Reports (43)
Research institute (2314)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (36)
Schizophrenia (59)
Series A (114)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1905)
Special edition (13)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (25)
United States (19563)
Vaccines (628)
Venture capitalists (35)
Webinars (12)
Weight loss (217)
Women's health (30)
Worklife (13)
Date
Today (4)
Last 7 days (673)
Last 30 days (2636)
Last 365 days (33972)
2025 (5896)
2024 (35219)
2023 (40076)
2022 (51176)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (213)
Arkansas (12)
Asia (37572)
Australia (6145)
California (5069)
Canada (1771)
China (419)
Colorado (232)
Connecticut (240)
Delaware (111)
Europe (80557)
Florida (748)
Georgia (174)
Idaho (57)
Illinois (467)
India (21)
Indiana (275)
Iowa (7)
Japan (128)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (781)
Massachusetts (3853)
Michigan (203)
Minnesota (348)
Mississippi (2)
Missouri (72)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1442)
New Mexico (27)
New York (1451)
North Carolina (871)
North Dakota (7)
Northern California (2225)
Ohio (179)
Oklahoma (13)
Oregon (32)
Pennsylvania (1154)
Puerto Rico (6)
Rhode Island (24)
South America (1093)
South Carolina (15)
South Dakota (1)
Southern California (1905)
Tennessee (84)
Texas (751)
Utah (155)
Virginia (118)
Washington D.C. (55)
Washington State (484)
West Virginia (3)
Wisconsin (44)
694,005 Results for "entos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster
Entos Pharmaceuticals (Entos or the Company), a clinical-stage biotechnology company developing genetic medicines with its proprietary Fusogenix PLV nucleic acid delivery platform, and its partner, Aegis Life, Inc. (Aegis), today announced that Entos has received approval from Health Canada to initiate a phase 1/2 clinical trial (NCT06436911) evaluating Covigenix VAX-002, an investigational COVID-19 booster vaccine.
June 10, 2024
·
6 min read
Press Releases
Entos Pharmaceuticals Awarded $4 Million USD in Funding from the California Institute for Regenerative Medicine (CIRM) for its Congenital Generalized Lipodystrophy Program
February 6, 2025
·
6 min read
Entos Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Entos Pharmaceuticals, (Entos), a genetic medicines company pioneering the development of life-changing medicines to patients with its Fusogenix PLV nucleic acid delivery technology, will be participating in the 2024 Bloom Burton & Co. Healthcare
April 9, 2024
·
2 min read
Entos Pharmaceuticals Launches GMP Clinical Manufacturing Facility in Carlsbad, California
Entos Pharmaceuticals announced the launch of its new Good Manufacturing Practices manufacturing facility in Carlsbad, California.
January 25, 2024
·
3 min read
Press Releases
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster
September 19, 2024
·
5 min read
Business
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos’ Fusogenix Drug Delivery Platform
Entos Pharmaceuticals, Inc. (Entos), a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, and BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that they have entered into an agreement that will see Entos apply its Fusogenix nucleic acid delivery technology to promising gene therapy candidates in the BioMarin pipeline.
November 15, 2021
·
3 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Entos Pharmaceuticals Expands R&D Operations into the US
Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle nucleic acid delivery platform, announced the opening of its new 9,600 square foot research and development facility in the Torrey Pines community of San Diego, California.
June 7, 2022
·
3 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Albertsons Companies, Inc. Announces CEO Succession Plan
March 3, 2025
·
8 min read
1 of 69,401
Next
